Treatment implications for young adult users of MDMA

Journal of Addictions and Offender Counseling

Volumn 26, Issue 2, 2006, Pages 84-98

  Dew, Brian J ^a   Elifson, Kirk W ^a   Sterk, Claire E ^b  

^a GEORGIA STATE UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34547426596     PISSN: 10553835     EISSN: 21611874     Source Type: Journal    
DOI: 10.1002/j.2161-1874.2006.tb00010.x     Document Type: Article

References (55)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
2. Anglin, M. D., Hser, Y., and Chou, C., (1993). Reliability and validity of retrospective behavioral self-report by narcotics addicts. Evaluation Review, 17, 91-103.
3. Back-Madruga, C., Boone, K., Chang, L., Grob, C., Lee, A., Nations, H., et al. (2003). Neuropsychological effects of 3, 4-Methylenedioxymethamphetamine (MDMA or Ecstasy) in recreational users. Clinical Neuropsychologist, 17, 446-459.
4. Blatt, S. J., D’Afflitti, J. P., and Quinlan, D. M., (1976). Depressive Experiences Questionnaire. New Haven, CT: Yale University Press.
5. Boeri, M. W., Sterk, C. E., and Elifson, K. W., (2004). Rolling beyond raves: Ecstasy use outside the rave setting. Journal of Drug Issues, 34, 831-860.
6. Broening, H., Morford, L., Inma-Wood, S., Fukumura, M., and Vorhees, C., (2001). 3, 4-Methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development. Journal of Neuroscience, 21(9), 3228-3235.
7. Cheek, J. M., and Buss, A. H., (1981). Shyness and sociability. Journal of Personality and Social Psychology, 41, 330-339.
8. Colado, M., O’Shea, E., and Green, A., (2004). Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Psychopharmacology, 173, 249-263.
9. Connor, T., (2004) Methylenedioxymethamphetamine (MDMA, “Ecstasy”): A stressor on the immune system. Immunology, 111, 357-367.
10. Corapcioglu, A., and Ogel, K., (2004). Factors associated with ecstasy use in Turkish students. Addiction, 99, 67-76.
11. Croft, R., Klugman, A., Baldeweg, T., and Gruzelier, J., (2001). Electrophysiological evidence of serotonergic impairment in long-term MDMA (“Ecstasy”) users. American Journal of Psychiatry, 158, 1687-1692.
12. Cuomo, M., and Dyment, P., (1994). Increasing use of ecstasy (MDMA) and other hallucinogens on a college campus. Journal of American College Health, 42, 214-226.
13. Curran, H., Rees, H., Hoare, R., and Bond, A., (2004). Empathy and aggression: Two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users. Psychopharmacology, 173, 425-433.
14. Dafters, R., Hoshi, R., and Talbot, A., (2004). Contribution of cannabis and MDMA (“Ecstasy”) to cognitive changes in long-term polydrug users. Psychopharmacology, 173, 405-410.
15. Daumann, J., Hensen, G., Thimm, B., Rezk, M., Till, B., and Gouzoulis-Mayfrank, E., (2004). Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: Further evidence from a combined cross-sectional/longitudinal investigation. Psychopharmacology, 173, 398-404.
16. Daumann, J., Pelz, S., Becker, S., and Tuchtenhagen, F., (2001). Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use. Human Psychopharmacology, 16, 627-633.
17. Dughiero, G., Schifano, F., and Forza, G., (2001). Personality dimensions and psychopathological profiles of Ecstasy users. Human Psychopharmacology, 16, 635-639.
18. Falk, R., Carlson, R., Wang, J., and Siegal, H., (2004). Sources of information about MDMA (3, 4-Methylenedioxymethamphetamine): Perceived accuracy, importance, and implications for prevention among young adult users. Drug and Alcohol Dependence, 74, 45-54.
19. Freese, T., Miotto, K., and Reback, C., (2002). The effects and consequences of selected club drugs. Journal of Substance Abuse Treatment, 23, 151-156.
20. Gahlinger, P., (2004). Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rohypnol, & Ketamine. American Family Physician, 69, 2619-2626.
21. Heffernan, T. M., Jarvis, H., Rodgers, J., Scholey, A. B., and Ling, J., (2001). Prospective memory, everyday cognitive failure and central executive function in recreational users of Ecstasy. Human Psychopharmacology, 16, 607-612.
22. Higgins, S., Budney, A., Bickel, W., Badger, G., Foerg, F., and Ogden, D., (1995). Outpatient behavioral treatment for cocaine dependence: One-year outcome. Experimental and Clinical Psychopharmacology, 3, 205-212.
23. Jansen, K., (1999). Ecstasy (MDMA) dependence. Drug and Alcohol Dependence, 53, 121-124.
24. Klitzman, R., Greenberg, J., Pollack, L., and Dolezal, C., (2002). MDMA (Ecstasy) use, and its association with high risk behaviors, mental health, and other factors among gay/bisexual men in New York City. Drug and Alcohol Dependence, 66, 115-125.
25. Kuniyoshi, S. M., and Jankovic, J., (2003). MDMA and Parkinsonism. New England Journal of Medicine, 349, 96-97.
26. Levenson, H., (1981). Differentiating among internality, powerful others, and chance. In H. M.Lefcourt (Ed.), Research with the locus of control construct (pp. 15-63). New York: Academic Press.
27. Maartje, M., Reneman, L., Reitsma, J., Heeten, G., Booij, J., and Brink, W., (2004). Mood disorders and serotonin transporter density in ecstasy: The influence of long-term abstention, dose, and gender. Psychopharmacology, 173, 376-382.
28. Martinez-Price, D., Krebs-Thomson, K., and Geyer, M., (2002). Behavioral psychopharmacology of MDMA and MDMA-like drugs: A review of human and animal studies. Addiction Research & Theory, 10, 43-67.
29. Martins, S., Mazzotti, G., and Chilcoat, H., (2005). Trends in ecstasy use in the United States from 1995 to 2001: Comparison with marijuana users and association with other drug use. Experimental and Clinical Psychopharmacology, 13(3), 244-252.
30. McCabe, S., Boyd, C., Hughes, T., and D’Arcy, H., (2003). Sexual identity and substance use among undergraduate students. Substance Abuse, 24(2), 77-91.
31. McCardle, K., Luebbers, S., Carter, J., Croft, R., and Stough, C., (2004). Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology, 173, 434-439.
32. McGregor, I., Gurtman, C., Morley, K., Clemens, K., Blokland, A., Li, K., et al. (2003). Increased anxiety and “depressive” symptoms months after MDMA (ecstasy) in rats: Drug-induced hyperthermia does not predict long-term outcomes. Psychopharmacology, 168, 465-474.
33. Milani, R., Parrott, A., Turner, J., and Fox, H., (2004). Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users. Addictive Behaviors, 29, 965-971.
34. Miller, H. G., Turner, C. F., and Moses, L. E., (1990). AIDS: The second decade. Washington, DC: Committee on AIDS Research and the Behavioral, Social, and Statistics Sciences, National Research Council, National Academy Press.
35. Moeller, F., Dougherty, D., Steinberg, J., Swann, A., Silverman, P., Ruiz, P., et al. (2002). Heavy “ecstasy1" use is associated with increased impulsivity. Addictive Disorders & Their Treatment, 1(2), 47-52.
36. Montoya, A., Sorrentino, R., Lukas, S., and Price, B., (2002). Long-term neuropsychiatric consequences of “Ecstasy” (MDMA): A review. Harvard Review of Psychiatry, 10, 212-220.
37. Morgan, M., (1998). Recreational use of “ecstasy” (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology, 19, 252-264.
38. National Institute on Drug Abuse. (2003). Monitoring the Future national survey results on adolescent drug use: Overview of key findings (NIDA Publication No. 03-5374). Bethesda, MD: Author.
39. Pape, H., and Rossow, I., (2004). Ordinary people with normal lives? A longitudinal study of ecstasy and other drug use among Norwegian youth. Journal of Drug Issues, 22, 389-418.
40. Parrott, A., Buchanan, T., Scholey, A., Heffernan, T., Ling, J., and Rodgers, J., (2002). Ecstasy/MDMA attributed problems reported by novice, moderate, and heavy recreational users. Human Psychopharmacology, 17, 309-312.
41. Ross, M., Mattison, A., and Franklin, D., (2003). Club drugs and sex on drugs are associated with different motivations for gay circuit party attendance in men. Substance Use and Misuse, 38, 1173-1183.
42. Rowe, C., Liddle, H., Greenbaum, P., and Henderson, C., (2004). Impact of psychiatric comorbidity on treatment of adolescent drug abusers. Journal of Substance Abuse Treatment, 26, 129-140.
43. Schifano, F., (2000). Potential human neurotoxicity of MDMA (Ecstasy): Subjective self-reports, evidence from an Italian drug addiction centre and clinical case studies. Neuropsychobiology, 42, 25-33.
44. Schifano, F., Leoni, M., Martinotti, G., Rawaf, S., and Rovetto, F., (2003). Importance of cyberspace for the assessment of the drug abuse market: Preliminary results from the Psychonaut 2002 project. Cyberpsychology & Behavior, 6, 405-410.
45. Solowij, N., Hall, W., and Lee, N., (1992). Recreational MDMA use in Sydney: A profile of Ecstasy users and their experiences with the drug. British Journal of Addictions, 87, 1161-1172.
46. Substance Abuse and Mental Health Services Administration. (2003). Results from the 2002 National Survey on Drug Use and Health: National findings. Rockville, MD: Author.
47. Sydow, K., Lieb, R., Pfister, H., Hofler, M., and Wittchen, H., (2002). Use, abuse, and dependence of ecstasy and related drugs in adolescents and young adults-a transient phenomenon? Results from a longitudinal community study. Drug and Alcohol Dependence, 66, 147-159.
48. Tashima, N., Crain, C., O’Reilly, K., and Sterk-Elifson, C., (1996). The community identification (CID) process: A discovery model. Qualitative Health Research, 6, 23-48.
49. Theall, K., Green, K., Kachur, R., and Elifson, K., (2001, July). “Just a little pill”: A snapshot of young adult ecstasy users in Atlanta, Georgia. Paper presented at the meeting of the National Institute on Drug Abuse’s MDMA/Ecstasy research: Advances, challenges, and future directions.
50. Urbach, B., Reynolds, K., and Yacoubian, G., (2002). Exploring the relationship between race and ecstasy involvement among a sample of arrestees. Journal of Ethnicity in Substance Abuse, 1, 49-61.
51. Walters, S., Foy, B., and Castro, R., (2002). The agony of ecstasy: Responding to growing MDMA use among college students. Journal of American College Health, 51, 139-141.
52. Watson, D., and Friend, R., (1969). Measurement of social-evaluative anxiety. Journal of Consulting and Clinical Psychology, 33, 448-457.
53. Yacoubian, G., Boyle, C., Harding, C., and Loftus, E., (2003). It’s a rave new world: Estimating the prevalence and perceived harm of ecstasy and other drug use among club rave attendees. Journal of Drug Education, 33, 187-196.
54. Yacoubian, G., Miller, S., Pianim, S., Kunz, M., Orrick, E., Link, T., et al. (2004). Toward an ecstasy and other club drug (EOCD) intervention for rave attendees. Journal of Drug Education, 34, 41-59.
55. U.S. Census Bureau. (2000). Statistical abstract of the United States. Washington, DC: Government Printing Office.